Anthony Lucci, MD, provides closing thoughts on the management of early-stage breast cancer moving forward given what we have learned from the COVID-19 pandemic.
48 Prevalence of “HER2 Ultra-Low” Among Advanced Breast Cancer Patients With Historical IHC0 Status